Overview

The overall objective is to define the neuropsychological profile of patients with migraine and evaluate its association with: psychological outcome measures (anxiety-depressive symptoms, pain catastrophizing, excessive worry, and coping strategies); the clinical profile of migraine; the prodromal, ictal, or interictal phase of the migraine attack; pharmacological therapy; and detoxification treatment in patients with migraine associated with medication overuse headache.

Eligibility

Inclusion Criteria:

• Written informed consent.
• Patients aged between 18 and 65 years.
• Diagnosis of migraine according to the International Classification of Headache Disorders (ICHD-3) criteria.
• Patients with a history of migraine for at least one year, to ensure the stability of the condition.
• Stability of ongoing treatment for at least 3 months at baseline.
• Understanding of the Italian language.

Exclusion Criteria:

• Severe medical or psychiatric conditions (depression, schizophrenia, psychosis) documented by specific previous diagnoses.
• A history of alcohol or drug abuse.
• Primary sensory deficits.